EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction: Synergistic antibacterial effects of postbiotics combined with linezolid and amikacin against nosocomial pathogens

Elif Yaprak Çolak, Nizami Duran

Frontiers in Cellular and Infection Microbiology · 08.06.2026 · 15

DOI: 10.3389/fcimb.2025.1750002 ↗

Kurz gefasst

Korrektur in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 08.06.2026. Verfasst von Elif Yaprak Çolak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Medical Faculty, Hatay Mustafa Kemal University, Antakya-Hatay, Türkiye. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

amikacinantimicrobial synergylinezolidmicrobiome therapynosocomial infectionspostbiotics

Autor:innen und Institutionen

  • Department of Medical Microbiology, Medical Faculty, Hatay Mustafa Kemal University, Antakya-Hatay, Türkiye.

Zitieren

APA

Yaprak Çolak, E., & Duran, N. (2026). Correction: Synergistic antibacterial effects of postbiotics combined with linezolid and amikacin against nosocomial pathogens. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1750002

Vancouver

Yaprak Çolak E, Duran N. Correction: Synergistic antibacterial effects of postbiotics combined with linezolid and amikacin against nosocomial pathogens. Frontiers in Cellular and Infection Microbiology. 2026;15. doi:10.3389/fcimb.2025.1750002

BibTeX
@article{Yaprakolak2026,
  author = {Yaprak Çolak, Elif and Duran, Nizami},
  title = {Correction: Synergistic antibacterial effects of postbiotics combined with linezolid and amikacin against nosocomial pathogens},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {15},
  doi = {10.3389/fcimb.2025.1750002}
}
Kostenlos starten →